Anecdotally, on-line case discussion forums for internal medicine specialists suggest that veterinary clinical usage of MMF for treatment of refractory
immune-mediated disease is now quite widespread, especially for acquired myasthenia gravis ,IMHA and pemphigus vulgaris. There is a need for prospective studies to justify and refine this usage and for preliminary studies to be documented in the literature.